Home Health iDBL
Interactive Drug Benefit List
DIN/NPN/ PIN Generic Name Product Name, Strength & Dosage Form Unit Price, Unit of Issue Manufacturer LCA Price MAC Price Interchangeable Products Coverage Status
02245531 FONDAPARINUX SODIUM ARIXTRA (0.5 ML SYRINGE) 2.5 MG / SYR INJECTION SYRINGE 12.2124
SYR 		APC 9.8620 N/A YES REGULAR BENEFIT Details
02406853 FONDAPARINUX SODIUM FONDAPARINUX SODIUM (0.5 ML SYRINGE) 2.5 MG / SYR INJECTION SYRINGE 9.8620
SYR 		DRL 9.8620 N/A YES REGULAR BENEFIT Details
02258056 FONDAPARINUX SODIUM ARIXTRA (0.6 ML SYRINGE) 7.5 MG / SYR INJECTION SYRINGE 21.6713
SYR 		APC 17.5000 N/A YES REGULAR BENEFIT Details
02406896 FONDAPARINUX SODIUM FONDAPARINUX SODIUM (0.6 ML SYRINGE) 7.5 MG / SYR INJECTION SYRINGE 17.5000
SYR 		DRL 17.5000 N/A YES REGULAR BENEFIT Details
DIN/NPN/ PIN 02245531
Generic Name FONDAPARINUX SODIUM
Product Name, Strength & Dosage Form ARIXTRA (0.5 ML SYRINGE) 2.5 MG / SYR INJECTION SYRINGE
Unit Price, Unit of Issue 12.2124
Manufacturer APC
LCA Price 9.8620
MAC Price N/A
Interchangeable Products YES
Coverage Status REGULAR BENEFIT
Details
DIN/NPN/ PIN 02406853
Generic Name FONDAPARINUX SODIUM
Product Name, Strength & Dosage Form FONDAPARINUX SODIUM (0.5 ML SYRINGE) 2.5 MG / SYR INJECTION SYRINGE
Unit Price, Unit of Issue 9.8620
Manufacturer DRL
LCA Price 9.8620
MAC Price N/A
Interchangeable Products YES
Coverage Status REGULAR BENEFIT
Details
DIN/NPN/ PIN 02258056
Generic Name FONDAPARINUX SODIUM
Product Name, Strength & Dosage Form ARIXTRA (0.6 ML SYRINGE) 7.5 MG / SYR INJECTION SYRINGE
Unit Price, Unit of Issue 21.6713
Manufacturer APC
LCA Price 17.5000
MAC Price N/A
Interchangeable Products YES
Coverage Status REGULAR BENEFIT
Details
DIN/NPN/ PIN 02406896
Generic Name FONDAPARINUX SODIUM
Product Name, Strength & Dosage Form FONDAPARINUX SODIUM (0.6 ML SYRINGE) 7.5 MG / SYR INJECTION SYRINGE
Unit Price, Unit of Issue 17.5000
Manufacturer DRL
LCA Price 17.5000
MAC Price N/A
Interchangeable Products YES
Coverage Status REGULAR BENEFIT
Details
To return to the printable Drug Benefit List and related publications, click here
Last Updated:
NOTICE:
The DBL, DBS and related publications require knowledgeable interpretation and are intended primarily for professional health care practitioners, pharmacies, hospitals and organizations associated with the manufacture, distribution and use of pharmaceutical preparations.
Electronic versions of all DBL and DBS related publications are unofficial versions and are provided for convenience and private use only. Official paper versions can be obtained from Alberta Blue Cross who publishes them on behalf of Alberta Health and Alberta Human Services.
Alberta Health reserves the right to make changes, without notice, to the List through the Interactive DBL(iDBL), and any such changes to the Interactive DBL(iDBL) are effective the date of the change (unless otherwise stated) and regardless of the date of publication in the paper version or updates.